GSK572A

CAS No. 1403602-32-3

GSK572A( —— )

Catalog No. M34273 CAS No. 1403602-32-3

GSK572A is a novel and potent potent inhibitor of EchA6, which can be used to treat tuberculosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 103 Get Quote
5MG 163 Get Quote
10MG 219 Get Quote
25MG 359 Get Quote
50MG 543 Get Quote
100MG 759 Get Quote
500MG 1557 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK572A
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK572A is a novel and potent potent inhibitor of EchA6, which can be used to treat tuberculosis.
  • Description
    GSK572A is a novel and potent potent inhibitor of EchA6, which can be used to treat tuberculosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1403602-32-3
  • Formula Weight
    447.43
  • Molecular Formula
    C22H21F4N5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NCC1=CC=C(F)C=N1)(=O)C2=C3N([C@H]([C@](F)(F)F)C[C@@H](N3)C4=CC=C(CC)C=C4)N=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • R121919

    R121919 (NBI30775) is a potent small molecule antagonist of the adrenocorticotropic hormone-releasing factor receptor 1 (CRF1), demonstrating antidepressant and anxiolytic activity, and inhibiting the CRF1 receptor, CRF2 receptor, and CRF-binding proteins.

  • Glutaminase-IN-1

    Glutaminase-IN-1 (CB839 derivative), a novel 1,3,4-selenodiazepine inhibitor of the renal-type glutaminase (KGA) variant, exhibited antitumor activity in an aggressive H22 hepatocellular carcinoma xenograft model.

  • Bellidifolin

    Bellidifolin shows the inhibition of monoamine oxidase activity.